A T cell-binding fragment of fibrinogen can prevent autoimmunity

Journal of Autoimmunity

Volumn 34, Issue 4, 2010, Pages 453-459

  Takada, Yoshikazu ^a   Ono, Yoko ^a   Sagusa, Jun ^a   Mitsiades, Constantine ^b   Mitsiades, Nicholas ^b   Tsai, Jean ^a   He, Yong ^a   Maningding, Ernest ^a   Coleman, Annie ^a   Ramirez Maverakis, Dalila ^a   Rodriquez, Raphael ^c   Takada, Yoko ^a   Maverakis, Emanual ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Department of Veteran Affairs Northern California Health Care System ^*  (United States)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis (EAE); MOG; Multiple sclerosis

Indexed keywords

CD3 ANTIBODY; FIBRINOGEN; FIBRINOGEN GAMMA CHAIN; GAMMA INTERFERON; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; BINDING SITE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG POTENCY; FEMALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNITY; BINDING SITES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FIBRINOGEN; LYMPHOCYTE ACTIVATION; MICE; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 77952237981     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.11.017     Document Type: Article

References (15)

1. Yee V.C., Pratt K.P., Cote H.C., Trong I.L., Chung D.W., Davie E.W., et al. Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen. Structure 1997, 5:125-138.
2. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
3. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003, 348:15-23.
4. Gordon F.H., Lai C.W., Hamilton M.I., Allison M.C., Srivastava E.D., Fouweather M.G., et al. A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology 2001, 121:268-274.
5. Gottlieb A.B., Krueger J.G., Wittkowski K., Dedrick R., Walicke P.A., Garovoy M. Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol 2002, 138:591-600.
6. Yokoyama K., Erickson H.P., Ikeda Y., Takada Y. Identification of amino acid sequences in fibrinogen gamma-chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3. J Biol Chem 2000, 275:16891-16898.
7. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860-864.
8. Flick M.J., Du X., Witte D.P., Jirouskova M., Soloviev D.A., Busuttil S.J., et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004, 113:1596-1606.
9. Menezes J.S., van den Elzen P., Thornes J., Huffman D., Droin N.M., Maverakis E., et al. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest 2007, 117:2176-2185.
10. Adams R.A., Bauer J., Flick M.J., Sikorski S.L., Nuriel T., Lassmann H., et al. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 2007, 204:571-582.
11. Barnden M.J., Allison J., Heath W.R., Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998, 76:34-40.
12. Yakubenko V.P., Solovjov D.A., Zhang L., Yee V.C., Plow E.F., Ugarova T.P. Identification of the binding site for fibrinogen recognition peptide gamma 383-395 within the alpha(M)I-domain of integrin alpha(M)beta2. J Biol Chem 2001, 276:13995-14003.
13. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 1989, 124:132-143.
14. Sutton C., Brereton C., Keogh B., Mills K.H., Lavelle E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006, 203:1685-1691.
15. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.